“…Similarly, Puig-Rigall et al 34 developed formulations of miltefosine (MF), an alkylphospholipid for breast cancer treatment, using TPGS, T1107 and T904 and noted improved activity of MF with T904 against intracellular amastigotes. Lecot et al 35 in a recent study used T1307 modified with a 4,4-difluoro-4-bora-3a,4a-diaza- s -indacene fluorophore for assessing it's in vivo biodistribution on 4T1 tumor-bearing mice and attained results revealing promising role of T1307 micelles as radio tracer agents for breast cancer imaging. Castelli et al 36 observed the co-association of aptamer Sgc8-c-Alexa647, a biomarker in cancer with different nanostructures like F127, T1307 and pegylated liposomes.…”